Literature DB >> 22715475

Influence of enterohepatic recycling on the time course of brain-to-blood partitioning of valproic acid in rats.

Jeannie M Padowski1, Gary M Pollack.   

Abstract

A widely used metric of substrate exposure in brain is the brain-to-serum partition coefficient (K(p,brain); C(brain)/C(serum)), most appropriately determined at distribution equilibrium between brain tissue and serum. In some cases, C(brain)/C(serum) can peak and then decrease, as opposed to monotonically increasing to a plateau, precluding accurate estimation of partitioning. This "overshoot" has been observed with compounds that undergo enterohepatic recycling (ER), such as valproic acid (VPA). Previous simulation experiments identified a relationship between overshoot in the C(brain)/C(serum) versus time profile and distribution into a peripheral "compartment" (e.g., the ER loop). This study was conducted to evaluate model predictions of that relationship. Initial experiments tested the ability of activated charcoal, antibiotics, or Mrp2 deficiency to impair VPA ER in rats, thereby limiting the apparent volume of distribution associated with ER. Mrp2 deficiency (significantly) and antibiotics (moderately) interrupted VPA ER. Subsequently, brain partitioning was evaluated in the presence versus absence of ER modulation. Although overshoot was not eliminated completely, deconvolution revealed that overshoot was reduced in Mrp2-deficient and antibiotic-treated rats. Consistent with model predictions, overshoot was higher after antibiotic treatment (moderate ER interruption) than in Mrp2 deficiency (substantial ER interruption). Steady-state K(p,brain) was unaffected by experimental manipulation, also consistent with model predictions. These data support the hypothesis that C(brain)/C(serum) may overshoot K(p,brain) based on the extent of peripheral sequestration. Consideration of this information, particularly for compounds that undergo significant extravascular distribution, may be necessary to avoid erroneous estimation of K(p,brain).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22715475      PMCID: PMC3422542          DOI: 10.1124/dmd.112.045500

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  35 in total

1.  Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding.

Authors:  T L Arens; G M Pollack
Journal:  Biopharm Drug Dispos       Date:  2001-09       Impact factor: 1.627

2.  Effect of mode of administration on drug distribution in a two-compartment open system.

Authors:  M Gibaldi
Journal:  J Pharm Sci       Date:  1969-03       Impact factor: 3.534

3.  Estimation of cerebral extraction of circulating compounds by the brain uptake index method: influence of circulation time, volume injection, and cerebral blood flow.

Authors:  J E Hardebo; B Nilsson
Journal:  Acta Physiol Scand       Date:  1979-10

4.  Testing for the equality of area under the curves when using destructive measurement techniques.

Authors:  A J Bailer
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

5.  Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice.

Authors:  C Dagenais; C Rousselle; G M Pollack; J M Scherrmann
Journal:  J Cereb Blood Flow Metab       Date:  2000-02       Impact factor: 6.200

6.  Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat.

Authors:  Andrew W E Wright; Ronald G Dickinson
Journal:  J Pharmacol Exp Ther       Date:  2004-04-09       Impact factor: 4.030

7.  Effects of antibiotic pretreatments on the metabolism and excretion of [U14C](+)-catechin [( U14C](+)-cyanidanol-3) and its metabolite, 3'-0-methyl-(+)-catechin.

Authors:  D M Gott; L A Griffiths
Journal:  Xenobiotica       Date:  1987-04       Impact factor: 1.908

8.  In vivo uptake of valproic acid into brain.

Authors:  E J Hammond; R J Perchalski; H J Villarreal; B J Wilder
Journal:  Brain Res       Date:  1982-05-20       Impact factor: 3.252

9.  Effect of activated charcoal on absorption of tolbutamide and valproate in man.

Authors:  P J Neuvonen; H Kannisto; E L Hirvisalo
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models.

Authors:  J H Lin; Y Sugiyama; S Awazu; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1982-12
View more
  2 in total

1.  Population pharmacokinetic model to analyze nevirapine multiple-peaks profile after a single oral dose.

Authors:  Manuel Ibarra; Marta Vázquez; Pietro Fagiolino
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-07-27       Impact factor: 2.745

2.  Enteric reabsorption processes and their impact on drug pharmacokinetics.

Authors:  Manuel Ibarra; Iñaki F Trocóniz; Pietro Fagiolino
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.